Keyphrases
Protease-activated Receptor 2 (PAR2)
100%
Bone Marrow
100%
Osteoclastogenesis
100%
Resorption
33%
Inflammation
33%
Surface Expression
33%
CD11b
33%
Osteoclast
33%
Ly6C
33%
Osteoclast Precursors
33%
Cartilage Destruction
16%
Expression Level
16%
Flow Cytometry
16%
Monocytes
16%
C57BL
16%
Flow Cytometric Analysis
16%
Circulating Monocytes
16%
G Protein-coupled Receptor
16%
Disease Activity
16%
Bone Remodeling
16%
Complete Freund's Adjuvant-induced Arthritis
16%
Serine Protease
16%
Rheumatoid Arthritis Patients
16%
Arthritis Models
16%
Bone Cartilage
16%
Bone Erosion
16%
Cellular Composition
16%
Ly6G
16%
CD117
16%
CD115
16%
Multinucleated Cells
16%
Osteoclast Differentiation
16%
Osteoresorption
16%
B220
16%
Osteolysis
16%
Overall Ratio
16%
Tartrate-resistant Acid Phosphatase
16%
Biochemistry, Genetics and Molecular Biology
Myeloid
100%
Protease-Activated Receptor 2
100%
Osteoclastogenesis
100%
Osteoclast
66%
Mouse
50%
Monocyte
33%
Surface Property
33%
Precursor
33%
C57BL 6 Mouse
16%
Serine Protease
16%
Osteolysis
16%
Bone Remodeling
16%
G Protein Coupled Receptor
16%
Tartrate-Resistant Acid Phosphatase
16%
CD117
16%
Flow Cytometry
16%
Immunology and Microbiology
Myeloid
100%
Osteoclastogenesis
100%
Osteoclast
80%
Mouse
60%
Monocyte
40%
Precursor
40%
Cartilage
20%
Arthritis
20%
Osteolysis
20%
Inflammatory Arthritis
20%
Surface Property
20%
CD3 Antigen
20%
C57BL 6 Mouse
20%
Cell Surface
20%
Freund's Adjuvant
20%
Bone Remodeling
20%
CD117
20%
Medicine and Dentistry
Proteinase Activated Receptor 2
100%
Osteoclastogenesis
100%
Osteoclast
66%
Precursor
33%
Monocyte
33%
Cartilage Degeneration
16%
In Vitro
16%
Adjuvant-Induced Arthritis
16%
Rheumatoid Arthritis
16%
C57BL/6
16%
Serine Proteinase
16%
Cell Surface
16%
Osteoplasty
16%
Osteolysis
16%
Disease Activity
16%
G Protein Coupled Receptor
16%
Flow Cytometry
16%
Bone Erosion
16%
Acid Phosphatase Tartrate Resistant Isoenzyme
16%